Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells.

By E. Jones, S. Kinsey, A. English, Richard A. Jones, Liz Straszynski, D. Meredith, A. Markham, A. Jack, P. Emery, D. Mcgonagle. Arthritis & Rheumatism, 2002

652 citations recorded by the source corpus.

Subfields: Genetics, Hematology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/c3150b796ea18d704fb9b7c12edfee75d4a4755d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

In Hematology

A. Keating

Citations in the corpus

Bone regeneration: current concepts and future directions (2011, background): “The in vivo phenotype of bone-marrow MSCs has been recently reported [53] and, even more recently, it has been shown that this population was actually fairly abundant in vivo in normal and pathological bone [54].”
Microfluidics for cell separation (2010, background): “Recently, various separation techniques have been successfully applied to separate stem cells based on their intrinsic properties to conduct fundamental studies [23, 24, 57].”
Mesenchymal stromal cells: new directions. (2012, background): “…marker to define MSCs, although a large number of different determinants have been associated, albeit not exclusively, with them (reviewed by Lindner et al., 2010 for human MSCs), including CD271 (low-affinity nerve growth factor receptor) (Jones et al., 2002) and CD146 (Sacchetti et al., 2007).”
Mesenchymal stem cell homing: the devil is in the details. (2009, neutral): “…environment, it is critical to consider the heterogeneity in MSC surface receptor expression and resulting MSC behavior that has been observed both within and between studies (Jones et al., 2002; da Silva Meirelles et al., 2006; Simmons and Torok-Storb, 1991; Sordi et al., 2005; Wynn et al., 2004).”
Aging of mesenchymal stem cells. (2006, background): “Recently, different surface markers have been associated with MSC including D7fib (Jones et al., 2002), Stro1 (Stenderup et al., 2001), CD45 and glycophorin A (Jones et al., 2004; Pittenger et al., 1999; Reyes et al., 2001), BMPR1a (Zvaifler et al., 2000) (for comparative analysis, see Young and…”
The Regulation of Differentiation in Mesenchymal Stem Cells (2010, neutral): “Indeed, MSCs are known to undergo phenotypic rearrangements during ex vivo manipulations, losing expression of some markers while acquiring new ones (Jones et al. , 2002).”
Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. (2007, positive): “To evaluate the specificity of the angiogenic signal induced by EPC-derived MVs, MVs were also purified from bone marrow-derived human mesenchymal stem cells (MSCs) isolated and characterized as previously described .(25) FACS and confocal microscopy analysis.”